- This forum has 1 topic, and was last updated 5 years ago by .
Viewing topic 1 (of 1 total)
-
- Topic
- Voices
- Last Post
Viewing topic 1 (of 1 total)
- You must be logged in to create new topics.
An online horse care and health guide
Welcome Guest! Do you need a reliable equine reference you could use at home, at the barn, even on the trail? Still have questions? How about access to a experienced equine veterinarian? You are 60 seconds away from access!
Come Join Us we have several options and the first month is FREE!
By the way, when you join not only is the whole site yours to enjoy but these ads disappear!
J Vet Pharmacol Ther 2002 Apr;25(2):81-7
Isoxsuprine hydrochloride in the horse: a review. Erkert RS, Macallister CG. Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK, USA. Isoxsuprine hydrochloride has been suggested for use in horses for treatment of navicular syndrome and laminitis. The drug has been shown to be a beta-adrenoreceptor antagonist with beta-adrenoreceptor agonistic properties, with both characteristics contributing to vasodilation and uterine relaxation. In addition, the drug is capable of decreasing blood viscosity and platelet aggregation. Studies have shown i.v. isoxsuprine to have a plasma half-life of <3 h with a large apparent volume of distribution. Cardiovascular effects resolve rapidly following i.v. administration, but are absent with oral dosing. Oral bioavailability is 2.2% with a high first pass effect. Isoxsuprine has an apparent affinity for melanin that may contribute to extended renal excretion. Clinical trials appear to support the use of isoxsuprine for treatment of navicular disease. However, poor bioavailability, lack of cardiovascular effects following oral administration, superficial support in clinical trials, and new evidence regarding the pathogenesis of navicular syndrome indicate that the use of isoxsuprine for treatment of navicular syndrome or laminitis is questionable at best. |